Pregnant and Parenting Women

Mom & Baby Substance Exposure Initiative

Project Overview

Through the Mother & Baby Substance Exposure Initiative (MBSEI), Health Management Associates (HMA) provided consultative services, coaching and other technical assistance (TA), on behalf of the California Department of Health Care Services (DHCS), to increase access to MAT using the three FDA-approved medications for the treatment of opioid use disorder (OUD). The goal of the initiative was to reduce unmet treatment needs and reduce opioid overdose related deaths through the provision of prevention, treatment and recovery activities for OUD. Additionally, the initiative aimed to decrease neonatal abstinence syndrome (NAS) severity and length of stay in the hospital, and to increase the number of mothers in long-term recovery.

The grant period was January 2019 to December 2020. During this time, HMA worked hand-in-hand with the California Maternal Quality Care Collaborative (CMQCC) and the California Perinatal Quality Care Collaborative (CPQCC) to deliver state-of-the-art treatment from the prenatal phase to the post-delivery phase. The outcomes include:

  • synthesis of information so that all programs and community-based service providers have access to the same information;
  • elimination of delays between treatment requests and medication starts;
  • standardized and improved addiction, pain management and related services available during delivery and the post-part period; 
  • standardized and improved hospital-based approaches to the management of NAS including preserving the mom-baby dyad in the postpartum period;
  • standardized and improved post-discharge pediatric services available to affected infants including reduction in punitive engagement with child protective services;
  • improved access to and help from Addiction Specialty care;
  • accurate information consumed by the public;
  • partners with large scale skill improvement and stigma abatement;
  • high fidelity and predictable practice methods with sustainable delivery;
  • information repository available for non-grantee locations; and
  • live dissemination of relevant information.

Throughout the website, the terms mother or maternal or she or her are used in reference to the birthing person. We recognize not all birthing people identify as mothers or women. We believe all birthing people are equally deserving of patient-centered care that helps them attain their full potential and live authentic, healthy lives.

Goals

  • Decrease NAS length of stay by decreasing NAS severity
  • Increase the number of moms identified
  • Decrease the number of Child Protective Service referrals
  • Increase the number of moms in long term recovery
  • Increase ability to identify and treat 50% of predicted individuals in the partners catchment area

Outcomes Achieved

  • Developed an outreach and implementation plan to build on the framework of existing treatment access points
  • Developed or build upon existing protocols, guidelines, safety bundles, and toolkits (NAS Toolkit)
  • Distributed OUD patient education materials
  • Coordinated learning collaboratives
  • Provided technical assistance
  • Developed a resource library

Locations

The Mother & Baby Substance Exposure Initiative will reach up to 12 counties.
  • Fresno
  • Humboldt
  • Lake
  • Los Angeles
  • Mendocino
  • Orange
  • San Diego
  • San Joaquin
  • Shasta
  • Stanislaus
  • Ventura

Short Webinars on Perinatal SUD

Health Management Associates (HMA) recorded and collated a series of videos that provide a brief overview of content related to perinatal substance use disorder and highlight the expertise of our subject matter experts (SMEs). HMA SMEs have direct experience leading and collaborating with organizations serving pregnant and parenting mothers with OUD, and their affected babies and families. These short videos, ranging in duration from 10-20 minutes, aim to briefly introduce the SMEs, expose you to a few of our areas of expertise, and provide useful content for your work with this population.

Impact

With the dissemination of patient and community level information, pregnant and/or parenting mothers can feel more comfortable within the healthcare system and see it as a refuge rather than an adversary. Along with this, we have implemented standardized approaches to pregnant and/or parenting women in the prehospital, hospital, and post-delivery phase in each of the participating counties.

For more information about Mother & Baby Substance Exposure Initiative, please contact Charles Robbins at crobbins@healthmanagement.com.

Upcoming Events (0)

No Upcoming Events

Please check back later to view our upcoming events.

Pregnant and Parenting Women Project Resources

Featured Resources

pregnant-and-parenting-women

Stories from Moms: Principals of Perinatal Substance Use

Webinar/Podcast/Video

open link in new page

For the past two years, the Mother and Baby Substance Exposure Initiative (MBSEI) has grounded itself in four principles of perinatal substance use: • Every pregnant woman should be screened • Every pregnant woman with OUD should be on MAT • Use non-pharmacologic treatment for NAS • Moms and Babies should receive support to keep them together Watch these principles come to life in a fifteen-minute video portraying the stories of moms and babies and the providers supporting them in navigating the perinatal substance use treatment system.

View
pregnant-and-parenting-women

Mother & Baby Substance Exposure Toolkit

Toolkit

open link in new page

This toolkit clarifies best practices to support and improve the care for substance exposed mothers and newborns.

View

Search For Project Resources

Use the below filters to narrow your search

All Resources (125)

pregnant-and-parenting-women

Mother & Baby Substance Exposure Toolkit

Toolkit

open link in new page

This toolkit clarifies best practices to support and improve the care for substance exposed mothers and newborns.

View
pregnant-and-parenting-women

Mother and Baby Substance Exposure Initiative Series: Stories from Moms – Principles of Perinatal Substance Use

November 20, 2020 - Webinar/Podcast/Video

open link in new page

For the past two years, the Mother and Baby Substance Exposure Initiative (MBSEI) has grounded itself in four principles of perinatal substance use: Every pregnant woman should be screene, Every pregnant woman with opioid use disorder should be on medication-assisted treatment, Use non-pharmacologic treatment for neonatal abstinence syndrome, and Moms and babies should receive support to remain together. We invite you to watch the final webinar in the MBSEI series as these four principles come to life in a 15-minute video portraying the stories of moms, babies and providers as they navigate the perinatal substance use treatment system. Following the video, experts working in the field participated in a moderated discussion and Q&A session.

pregnant-and-parenting-women

Addressing SDHs Among Pregnant Women, Mothers with Substance Use Disorder

October 26, 2020 - Webinar/Podcast/Video

open link in new page

Please watch this informative, engaging, and practical discussion on addressing social determinants of health among women and babies exposed to opioid use disorder (OUD) and substance use disorder (SUD). HMA experts focus on housing insecurity and domestic violence among the various social determinants of health affecting the overall quality of life. health risks and outcomes impacting pregnant women and mothers with OUD/SUD. Speakers also address social and community resources and structures supporting health and wellbeing in the places where this population lives, learns, works and plays.

pregnant-and-parenting-women

Navigating Stigma and Bias via Motivational Interviewing for Pregnant and Parenting Women

November 13, 2020 - Webinar/Podcast/Video

open link in new page

Pregnant and parenting women with substance use challenges face many social barriers including misperceptions, judgment and stigma. These experiences can also occur in the process of their seeking healthcare. It is the aim of these presentations to provide clinicians and teams with enhanced awareness, knowledge and skills toward the elimination of health inequities and improved patient experience of care.

pregnant-and-parenting-women

Toxicology - What You Need to Know for Your Busy Practice

May 21, 2020 - Webinar/Podcast/Video

open link in new page

In this webinar, Dr. Shannon Robinson will discuss current concepts regarding toxicological testing. These include ensuring you are able to detect the substances you are looking for and ways to address inconsistent results without increasing patient resistance. 

pregnant-and-parenting-women

MBSEI Webinar Series: Enhancing Child Welfare Support for Families affected by SUD/OUD - A Two-Part Session (Part 1)

September 22, 2020 - Webinar/Podcast/Video

open link in new page

In partnership with the OC Social Services Agency, Health Management Associates invites you to register and join us for a two-part webinar on Enhancing Child Welfare Support for Families affected by Substance Use Disorder/Opioid Use Disorder. THE SESSIONS WILL COVER: Family connection and resilience, Collaborative case planning, Safety organized practice and core practice model, Community child protection ecosystem, Collaborative case planning. THIS TRAINING IS APPROPRIATE FOR SUPERVISORS, MANAGERS, AND COURT OFFICIALS.

pregnant-and-parenting-women

Introducing the Mother & Baby Substance Exposure Toolkit

March 13, 2020 - Webinar/Podcast/Video

open link in new page

In this webinar, Corey Waller, MD, MS; Holly Smith, MPH, MSN, CNM; Carrie Griffin, DO; Kathryn Ponder, MD; and Jadene Wong, MD discuss the Mother & Baby Substance Exposure Toolkit. This toolkit clarifies best practices to support and improve the care for substance exposed mothers and newborns. 

View
pregnant-and-parenting-women

Treating Pregnant Women with OUD/SUD During the COVID-19 Pandemic in San Joaquin County

June 30, 2020 - Webinar/Podcast/Video

open link in new page

In partnership with San Joaquin County, Health Management Associates presented an informative, engaging and practical presentation about treating pregnant women with Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) during the COVID-19 Pandemic. We heard from Dr. Helen DuPlessis - Director of the Mother and Baby Substance Exposure Initiative (MBSEI), and Shelly Virva - MBSEI Subject Matter Expert.

pregnant-and-parenting-women

Treating Pregnant Women with OUD/SUD During the COVID-19 Pandemic in Sacramento County

May 14, 2020 - Webinar/Podcast/Video

open link in new page

In partnership with Sacramento County, Health Management Associates presented an informative, engaging and practical presentation about treating pregnant women with Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) during the COVID-19 pandemic. We heard from Dr. Helen DuPlessis - Director of the Mother and Baby Substance Exposure Initiative, and Shelly Virva - MBSEI Subject Matter Expert.

pregnant-and-parenting-women

Treating Pregnant Women with OUD/SUD During the COVID-19 Pandemic in Fresno County

July 7, 2020 - Webinar/Podcast/Video

open link in new page

In partnership with Fresno County, Health Management Associates presented an informative, engaging and practical presentation about treating pregnant women with Opioid Use Disorder (OUD)/Substance Use Disorder (SUD) during the COVID-19 Pandemic. We heard from Dr. Helen DuPlessis - Director of the Mother and Baby Substance Exposure Initiative (MBSEI), and Shelly Virva - MBSEI Subject Matter Expert.

pregnant-and-parenting-women

The Impact of Fentanyl on Mothers and Babies: A Pharmacological Perspective

July 29, 2020 - Webinar/Podcast/Video

open link in new page

In this webinar we discuss how pregnant women and their newborns are affected by the rising incidence of fentanyl and fentanyl  analogues in the drug supply. Special focus will be placed on the pharmacokinetics and pharmacodynamic changes occurirng during pregnancy and the post-partum period.  

pregnant-and-parenting-women

The Courts and Perinatal Substance Use: Evidence and Conundrums in Diagnosis, Treatment and Consequences

November 18, 2020 - Webinar/Podcast/Video

open link in new page

In partnership with the OC Juvenile Courts, Health Management Associates invites you to register and join us for a webinar called: The Courts and Perinatal Substance Use: Evidence and Conundrums in Diagnosis, Treatment and Consequences. Health Management Associates (HMA) is providing training and technical assistance in 12 California counties to address substance and opioid use disorder in the perinatal population. This interactive workshop – provided by the leadership of the Mom and Baby Substance Exposure Initiative, a state opioid response grantee – will include a discussion of current evidence, best practices and information about perinatal substance use.

Viewing 12 of 125 resources